The LIVERATION project team

Expected Potential of Pragmatic Clinical Trials

Pragmatic clinical trials hold significant promise for advancing medical research and improving patient care. Unlike traditional randomized controlled trials, pragmatic trials are designed to evaluate interventions in real-world settings, reflecting the diversity and complexity of routine clinical practice.

The expected potential of pragmatic clinical trials lies in their ability to generate evidence that is directly applicable to everyday clinical decision-making. By studying the impact of interventions in diverse patient populations and real-world conditions, pragmatic trials can provide valuable insights into the effectiveness, safety, and cost-effectiveness of treatments. Through the LIVERATION project’s ambitious multicenter clinical trial, we aim to unlock new knowledge that can directly inform liver cancer treatment strategies and ultimately improve patient outcomes.

This dynamic platform serves as a repository of curated scientific articles, research papers, and resources, all contributing to a deeper understanding of liver cancer treatment and patient care.

Within this Hub, you will find a wealth of evidence, insights, and data from our multicenter clinical trial, shedding light on the impact of additional ablated margins produced by radiofrequency on CRLM and hepatocellular carcinoma.

From peer-reviewed publications to informative sources, the Hub is designed to foster knowledge exchange and promote evidence-based decision-making in liver cancer management. We invite you to explore and immerse yourself in the vast array of resources available here, empowering you to join us in the fight against liver cancer and the pursuit of improved patient outcomes.

Hub of articles

Professionals Leaflet

Policy makers Leaflet

Skip to content